Physician profile
Catherine Baston
NPI 1992952865
$1,096.43
in general payments reported to CMS, 2019-2025
14 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $33.40 · 2021: $67.98 · 2022: $277 · 2023: $179 · 2024: $258 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $395.79 | 2022-2025 | Scoutpro Osmolarity System, Infuse, Vyzulta |
| Alcon Vision LLC | $141.40 | 2019-2025 | Hydrus Microstent, Argos |
| Genentech USA, INC. | $127.81 | 2023 | Vabysmo |
| Harrow Eye, LLC | $112.43 | 2024-2025 | Vevye, Iheezo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $85.89 | 2020-2021 | |
| Lensar, INC. | $52.19 | 2024-2025 | Lensar Laser System |
| Sun Pharmaceutical Industries INC. | $37.54 | 2019 | |
| Zimmer Biomet Holdings, INC. | $30.07 | 2025 | Mymobility Platform |
| Glaukos Corporation | $28.76 | 2022 | |
| Rayner Intraocular Lenses Limited | $26.28 | 2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Allergan, INC. | $18.64 | 2019 | |
| Aerie Pharmaceuticals, INC. | $13.60 | 2019 | |
| Shire North American Group INC | $13.24 | 2019 | |
| Horizon Therapeutics Plc | $12.79 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Baston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.